Evidence map›Paper›PMID 28262754›Full record

ArticleScientific reports2017

Engineered yeast with a CO

Yun-Jie Li, Miao-Miao Wang, Ya-Wei Chen, Meng Wang, Li-Hai Fan, Tian-Wei Tan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Coordinating Calvin Cycle and Glycolysis inACS synthetic biology · 2026
    Article
  3. Article
  4. Engineering COInternational journal of molecular sciences · 2025
    Article
  5. Review
  6. Article
  7. Probing efficient microbial COMicrobial biotechnology · 2024
    Article
  8. Article
  9. Review
  10. Prospects for engineeringEngineering microbiology · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Biosynthesis Based on One-Carbon Mixotrophy.Advances in biochemical engineering/biotechnology · 2022
    Article
  17. Reprogramming Microbial COFrontiers in bioengineering and biotechnology · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yun-Jie LiCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, People's Republic of China.
Miao-Miao WangCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, People's Republic of China.
Ya-Wei ChenCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, People's Republic of China.
Meng WangCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, People's Republic of China.
Li-Hai FanCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, People's Republic of China.
Tian-Wei TanCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, People's Republic of China.
Beijing University of Chemical Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bio-ethanol production from lignocellulosic raw materials could serve as a sustainable potential for improving the supply of liquid fuels in face of the food-to-fuel competition and the growing energy demand. Xylose is the second abundant sugar of lignocelluloses hydrolysates, but its commercial-scale conversion to ethanol by fermentation is challenged by incomplete and inefficient utilization of xylose. Here, we use a coupled strategy of simultaneous maltose utilization and in-situ carbon dioxide (CO

Indexed as

Base SequenceCarbon DioxideEthanolFermentationIndustrial MicrobiologyMaltoseMetabolic EngineeringNADOxidation-ReductionReproducibility of ResultsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSugarsXyloseCarbon DioxideEthanolMaltoseNADSaccharomyces cerevisiae ProteinsSugarsXylose

Identifiers

PMID28262754
PMCPMC5338314
OpenAlexW2592811063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.